Learn More
Lkt Laboratories CAS 62996-74-1, ≥98%, PKC and mammalian RNA splicing inhibitor produced by Streptomyces. It is a precursor in the synthesis of K252c.

Supplier: Lkt Laboratories S7600
Staurosporine is an alkaloid initially produced by Streptomyces that inhibits PKC and other protein kinases. Staurosporine is a precursor in the synthesis of kinase inhibitors K252c and PKC412. This compound exhibits anticancer, anti-parasitic, and anti-protozoan activities. Staurosporine induces apoptosis in hepatocarcinoma cells by decreasing levels of p38 MAPK, pERK, and DNA methyltransferase 3B (DNMT 3B) and increasing levels of pJNK. Staurosporine also causes cell death in Trypanosoma. This compound also inhibits mammalian RNA splicing.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.